-
NMPA Held 2023 ICH in China: Progress and Outlook Symposium
2023-09-13
On September 12, NMPA held 2023 ICH in China: Progress and Outlook Symposium in Beijing, to make dialogue on development and cooperation with representatives from domestic and foreign industry associations.
-
Narlumosbart Injection Approved with Conditions for Marketing by China NMPA
2023-09-06
Recently, the Narlumosbart Injection (Chinese trade name: 津立生) of Shanghai JMT Biological Technology Co. Ltd. is approved with conditions through the priority review and approval procedure by China NMPA.
-
Hip Replacement Navigation Positioning System Approved for Marketing
2023-08-11
Recently, the innovative product Hip Replacement Navigation Positioning System of Hangzhou Lancet Robotics company is approved by China NMPA.
-
Rigid Scleral Contact Lens Approved for Marketing
2023-08-03
Recently, the innovative product Rigid Scleral Contact Lens of Shanghai Aikangte Medical Technology Co., Ltd. is approved by China NMPA.
-
Medical Electronic Linear Accelerator Approved for Marketing
2023-08-01
Recently, the innovative product Medical Electronic Linear Accelerator of Xian OUR UNITED Corp. is approved by China NMPA.
-
Carbon Ion Therapy System Approved for Marketing
2023-06-03
Recently, the innovative product Carbon Ion Therapy System of Lanzhou Ion Therapy Co., Ltd. is approved by China NMPA.
